期刊文献+

阿米卡星在老年呼吸系统感染患者体内的药动学研究 被引量:4

The Pharmacokinetics Study of Amikacin in Old Patients with Respiratory System Infections
下载PDF
导出
摘要 目的 :研究阿米卡星 (AMK)在老年呼吸系统感染患者体内的药动学 ,为临床合理用药提供依据。方法 :用荧光偏振免疫方法测定药物的血药浓度。结果 :AMK的药 -时曲线符合二房室模型。AMK在健康志愿者和老年呼吸系统感染患者体内的T1/2β 分别为 (2 14±0 81)h、(4 32±1 05)h ;AUC分别为 (70 68±26 47) (mg·h)/L、(101 83±9 73) (mg·h)/L。结论 OBJECTIVE:The pharmaceutics of Amikacin(AMK)in old patients with respiratory system infections was studied to provide a basis for clinical use.METHODS:Fluorescence polarizing immunoassay method was employed to detect blood drug concentration.RESULTS:The blood concentration-time curve of AMK fitted in with the two-compartment modˉel.The T 1/2β and AUC of AMK in the healthy volunteers and old patients with respiratory system infections were(2.14±0.81)h and(4.32±1.05)h(P<0.01),and(70.68±26.47)(mg·h)/L and(101.83±9.73)(mg·h)/L respectively(P<0.01).CONCLU SION:The pharmacokinetic process of AMK in the old patients with respiratory system infections is obviously different from that in the healthy volunteers.
作者 陈海燕 何威
出处 《中国药房》 CAS CSCD 2004年第1期39-40,共2页 China Pharmacy
关键词 阿米卡星 老年患者 药动学 Amikacin old patients pharmacokinetics
  • 相关文献

参考文献4

  • 1[1]Donald PR, Sirgel FA, Venter A, et al. The early bac_ tericidal activity of amikacin in pulmonary tuberculosis[J]. Int J Tuberc Lung Dis, 2001, 5( 6): 533.
  • 2[2]Hosokawa H, Nyu S, Nakamura K, et al. Circadian va_ riation in amikacin clearance and its effects on efficacy and toxicity in mice with and without immunosuppression[J]. Chronobiol Int., 1993, 10( 4): 259.
  • 3[3]Fujimura A, Sudoh T, Ebihara A. Time- dependent change in the toxic effects of amikacin on renal functions[J]. Life Sci, 1994, 55( 5): 367.
  • 4[4]Belfayol L, Talon P, Eveillard M, et al. Pharmacokin_ etics of once- daily amikacin in pediatric patients[J]. Clin Microbiol Infect, 1996, 2( 3): 186.

同被引文献33

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部